Prime Medicine, Inc. Operating CF per Share

Operating CF per Share of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF per Share growth rates and interactive chart. Total operating cash flow in a period divided by the weighted average number of shares outstanding. A company with $100 million in operating cash flow and 10 million weighted average shares will have operating cash flow per share of $10.

Highlights and Quick Summary

  • Operating CF per Share for the quarter ending September 30, 2023 was -0.43 (a -5.5% decrease compared to previous quarter)
  • Year-over-year quarterly Operating CF per Share decreased by -52.95%
  • Annual Operating CF per Share for 2022 was -3.89 (a 48.06% increase from previous year)
  • Annual Operating CF per Share for 2021 was -2.63 (a 25.1% increase from previous year)
  • Twelve month Operating CF per Share ending September 30, 2023 was -1.66 (a 4.74% increase compared to previous quarter)
  • Twelve month trailing Operating CF per Share decreased by -57.38% year-over-year
Trailing Operating CF per Share for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
-1.66 -1.58 -1.38 -3.89
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF per Share of Prime Medicine, Inc.

Most recent Operating CF per Shareof PRME including historical data for past 10 years.

Interactive Chart of Operating CF per Share of Prime Medicine, Inc.

Prime Medicine, Inc. Operating CF per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -0.43 -0.45 -0.47 – –
2022 -0.91 -1.35 -1.0 -2.67 -3.89
2021 – – 0.0 -1.4 -2.63
2020 0.0 – – – -2.1

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com